{"id":"https://openalex.org/W1967754591","doi":"https://doi.org/10.1186/1939-4551-6-s1-p162","title":"Immunotherapy \u2013 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses","display_name":"Immunotherapy \u2013 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1967754591","doi":"https://doi.org/10.1186/1939-4551-6-s1-p162","mag":"1967754591"},"language":"en","primary_location":{"id":"doi:10.1186/1939-4551-6-s1-p162","doi":"https://doi.org/10.1186/1939-4551-6-s1-p162","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1939-4551-6-s1-p162","pdf_url":"http://www.worldallergyorganizationjournal.org/article/S1939455119308488/pdf","source":{"id":"https://openalex.org/S49523212","display_name":"World Allergy Organization Journal","issn_l":"1939-4551","issn":["1939-4551"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Allergy Organization Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.worldallergyorganizationjournal.org/article/S1939455119308488/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029809747","display_name":"Roderick Peter Hafner","orcid":"https://orcid.org/0000-0002-9082-733X","observed_orcids":["https://orcid.org/0000-0002-9082-733X"]},"institutions":[{"id":"https://openalex.org/I4210088056","display_name":"Circassia Pharmaceuticals (United Kingdom)","ror":"https://ror.org/003g5qe79","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088056"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Roderick Peter Hafner","raw_affiliation_strings":["Circassia Limited, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Circassia Limited, Oxford, UK","institution_ids":["https://openalex.org/I4210088056"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026361524","display_name":"Peter R. Couroux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Couroux","raw_affiliation_strings":["Cetero Research, Missisauga, ON, Canada","Cetero Research, Missisauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cetero Research, Missisauga, ON, Canada","institution_ids":[]},{"raw_affiliation_string":"Cetero Research, Missisauga, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046088227","display_name":"A. Salapatek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annemarie Salapatek","raw_affiliation_strings":["Cetero Research, Missisauga, ON, Canada","Cetero Research, Missisauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cetero Research, Missisauga, ON, Canada","institution_ids":[]},{"raw_affiliation_string":"Cetero Research, Missisauga, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064597065","display_name":"Pascal Hickey","orcid":"https://orcid.org/0000-0002-2688-7178","observed_orcids":["https://orcid.org/0000-0002-2688-7178"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pascal Hickey","raw_affiliation_strings":["Adiga Life Sciences Inc., Hamilton, ON, Canada","Adiga Life Sciences Inc., Hamilton, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adiga Life Sciences Inc., Hamilton, ON, Canada","institution_ids":[]},{"raw_affiliation_string":"Adiga Life Sciences Inc., Hamilton, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul Laidler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088056","display_name":"Circassia Pharmaceuticals (United Kingdom)","ror":"https://ror.org/003g5qe79","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088056"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Laidler","raw_affiliation_strings":["Circassia Limited, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Circassia Limited, Oxford, UK","institution_ids":["https://openalex.org/I4210088056"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077280281","display_name":"Mark Larch\u00e9","orcid":"https://orcid.org/0000-0002-1439-7593","observed_orcids":["https://orcid.org/0000-0002-1439-7593"]},"institutions":[{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark Larch\u00e9","raw_affiliation_strings":["Department of Medicine, Mcmaster University, Hamilton, ON, Canada","Dept. of Medicine, McMaster University, Hamilton, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Mcmaster University, Hamilton, ON, Canada","institution_ids":["https://openalex.org/I98251732"]},{"raw_affiliation_string":"Dept. of Medicine, McMaster University, Hamilton, Canada","institution_ids":["https://openalex.org/I98251732"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111389568","display_name":"Deepen Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deepen Patel","raw_affiliation_strings":["Cetero Research, Missisauga, ON, Canada","Cetero Research, Missisauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cetero Research, Missisauga, ON, Canada","institution_ids":[]},{"raw_affiliation_string":"Cetero Research, Missisauga, Canada","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029809747"],"corresponding_institution_ids":["https://openalex.org/I4210088056"],"apc_list":{"value":2840,"currency":"EUR","value_usd":3508},"apc_paid":{"value":2840,"currency":"EUR","value_usd":3508},"fwci":0.6455,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.74344791,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"6","issue":null,"first_page":"P162","last_page":"P162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cat-allergy","display_name":"cat allergy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/fel-d-1","display_name":"Fel d 1","score":0.9399999976158142},{"id":"https://openalex.org/keywords/allergen-immunotherapy","display_name":"allergen immunotherapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/t-cell-epitopes","display_name":"T cell epitopes","score":0.9200000166893005},{"id":"https://openalex.org/keywords/rhinoconjunctivitis","display_name":"rhinoconjunctivitis","score":0.7279999852180481},{"id":"https://openalex.org/keywords/nasal-symptoms","display_name":"nasal symptoms","score":0.6819999814033508},{"id":"https://openalex.org/keywords/ocular-symptoms","display_name":"ocular symptoms","score":0.9860000014305115},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6159999966621399},{"id":"https://openalex.org/keywords/allergen-challenge","display_name":"allergen challenge","score":0.5730000138282776},{"id":"https://openalex.org/keywords/environmental-exposure-chamber","display_name":"environmental exposure chamber","score":0.6769999861717224},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.942305326461792},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7575212121009827},{"id":"https://openalex.org/C2779779143","wikidata":"https://www.wikidata.org/wiki/Q3493547","display_name":"Desensitization (medicine)","level":3,"score":0.7452832460403442},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6076756715774536},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.5857483148574829},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5127893090248108},{"id":"https://openalex.org/C2780510475","wikidata":"https://www.wikidata.org/wiki/Q186752","display_name":"Allergen","level":3,"score":0.4324771761894226},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3938792049884796},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28830212354660034},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09637993574142456},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06090056896209717},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1186/1939-4551-6-s1-p162","doi":"https://doi.org/10.1186/1939-4551-6-s1-p162","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1939-4551-6-s1-p162","pdf_url":"http://www.worldallergyorganizationjournal.org/article/S1939455119308488/pdf","source":{"id":"https://openalex.org/S49523212","display_name":"World Allergy Organization Journal","issn_l":"1939-4551","issn":["1939-4551"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Allergy Organization Journal","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2647191","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3643481","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3643481","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3643481","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Allergy Organ J","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/1939-4551-6-s1-p162","doi":"https://doi.org/10.1186/1939-4551-6-s1-p162","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1939-4551-6-s1-p162","pdf_url":"http://www.worldallergyorganizationjournal.org/article/S1939455119308488/pdf","source":{"id":"https://openalex.org/S49523212","display_name":"World Allergy Organization Journal","issn_l":"1939-4551","issn":["1939-4551"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Allergy Organization Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1967754591.pdf","grobid_xml":"https://content.openalex.org/works/W1967754591.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1511613086","https://openalex.org/W2007741297","https://openalex.org/W2067802926","https://openalex.org/W1952624284","https://openalex.org/W2153343942","https://openalex.org/W2157585958","https://openalex.org/W1967712856","https://openalex.org/W1998836879","https://openalex.org/W2074525021","https://openalex.org/W2168847048"],"abstract_inverted_index":{"This":[0],"article":[1],"was":[2,211,333],"originally":[3],"published":[4],"online":[5],"on":[6,75,99,198,202,266,286],"23":[7],"April":[8],"2013":[9],"Previously,":[10],"we":[11,42],"identified":[12],"a":[13,100,150,163,176,194,251,262,270,282,296,330,339],"series":[14],"of":[15,45,54,80,102,131,137,142,168,191,196,259,264,279,284,293,309,325,329,338],"T-cell":[16],"epitopes":[17],"from":[18],"the":[19,39,46,61,125,135,171,180,187,222,225,242,274,304,315,323],"major":[20],"cat":[21,35,310],"allergen":[22,82],"Fel":[23],"d1":[24,85],"and":[25,30,91,161,200,218,269,303,306,342],"showed":[26,175,250,295],"these":[27],"were":[28,106,145,159],"safe":[29],"well-tolerated":[31],"when":[32],"administered":[33],"to":[34,108,147,215,335],"allergic":[36],"subjects.":[37],"In":[38],"current":[40],"study,":[41],"evaluated":[43],"persistence":[44],"treatment":[47,58,143,226,246,345],"effect":[48,227,346],"(tolerance)":[49],"one":[50,320,350],"year":[51,321,351],"after":[52,134,140,322],"start":[53,136,324],"dosing":[55],"for":[56,127,209],"two":[57],"regimens":[59],"with":[60,247,290],"same":[62],"cumulative":[63],"dose.":[64],"Subjects":[65,87,123],"underwent":[66],"Baseline":[67],"Challenge":[68],"in":[69,149,170,179,206,254,273,299,314],"an":[70],"Environmental":[71],"Exposure":[72],"Chamber":[73],"(EEC)":[74],"4":[76,128,165],"consecutive":[77,129,166],"days,":[78,130,167],"consisting":[79],"3-hour":[81],"exposures":[83],"(Fel":[84],"50.19\u00b13.70ng/m3).":[86],"scored":[88],"four":[89,92,291],"nasal":[90,307],"ocular":[93,305],"symptoms":[94],"every":[95],"30":[96],"minutes":[97],"each":[98],"scale":[101],"0-3.":[103],"202":[104],"subjects":[105,144,158],"randomised":[107],"placebo,":[109],"8x3nmol":[110,199,219],"Cat":[111],"Peptide":[112],"Antigen":[113],"Desensitisation":[114],"(Cat-PAD)":[115],"2weeks(wk)":[116],"apart":[117],"or":[118],"4x6nmol":[119,173,210,223,248],"Cat-PAD":[120,174,249,294],"4wk":[121],"apart.":[122],"re-attended":[124],"EEC":[126,189,244,316],"3-hours,":[132],"18-22wk":[133,236],"treatment.":[138,326],"50-54wk":[139,188],"commencement":[141],"invited":[146],"participate":[148],"blinded":[151],"follow-on":[152],"study":[153],"without":[154],"further":[155,164],"dosing.":[156],"89":[157],"enrolled":[160],"had":[162],"3-hours":[169],"EEC.":[172],"mean":[177,252,271],"change":[178,195,205,253,263,272,283],"Total":[181,255,275],"Rhinoconjunctivitis":[182],"Symptom":[183,257,277],"Score":[184,258,278],"(TRSS)":[185],"at":[186,228,235,349,353],"visit":[190,245],"-6.78\u00b15.71":[192],"versus":[193,261,281],"-3.89\u00b15.56":[197],"-2.91\u00b15.56":[201],"placebo.":[203,343],"The":[204,344],"TRSS":[207],"score":[208],"statistically":[212],"significantly":[213],"different":[214],"placebo":[216,239,267,287],"(p=0.01)":[217],"(p=0.03).":[220],"For":[221],"regimen,":[224],"50-54w":[229,243],"trended":[230,347],"higher":[231,348],"than":[232,352],"that":[233,318],"seen":[234],"(4x6nmol":[237],"-5.41\u00b15.80;":[238],"-2.79\u00b15.28).":[240],"At":[241],"Nasal":[256],"-3.44\u00b13.05":[260],"-1.63\u00b12.95":[265],"(p=0.02)":[268],"Ocular":[276],"-3.34\u00b13.05":[280],"-1.28\u00b12.92":[285],"(p=0.01).":[288],"Treatment":[289],"injections":[292],"substantial":[297],"reduction":[298],"patients\u2019":[300],"overall":[301],"TRSS,":[302],"components":[308],"allergy":[311],"symptom":[312],"scores":[313],"model":[317],"persisted":[319],"Four":[327],"administrations":[328,337],"6nmol":[331],"dose":[332,341],"superior":[334],"eight":[336],"3nmol":[340],"18-22wk.":[354]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}